Are Global Cord (NYSE:CO) conflicting basic indicators contributing to the latest slide?


USD 2.99  0.77  34.68%   

Global Cord Debt to Equity Ratio is quite stable at the moment as compared to the past year. The company's current value of Debt to Equity Ratio is estimated at 0.89. EBITDA Margin is expected to rise to 0.56 this year, although the value of Average Assets will most likely fall to about 7.3 B. Global Cord Blood is scheduled to announce its earnings today. While some of us are getting worried about healthcare space, it is reasonable to outline Global Cord Blood using its current fundamental data. We will evaluate why we are still confident in anticipation of a recovery. Will institutional investors continue to hold, or should we expect a sell-off?
Published over two months ago
View all stories for Global Cord | View All Stories
Global Cord is UNDERVALUED at 3.29 per share with modest projections ahead.
Global Cord Blood holds Efficiency (Sharpe) Ratio of -0.13, which attests that the entity had -0.13% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Global Cord Blood exposes twenty-one different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Global Cord risk adjusted performance of (0.13), and Market Risk Adjusted Performance of (1.34) to validate the risk estimate we provide.
Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Global Cord income statement, its balance sheet, and the statement of cash flows. Potential Global Cord investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Global Cord investors may use each financial statement separately, they are all related. The changes in Global Cord's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Global Cord's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
The goal of Global Cord fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Global Cord performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Global Cord shares is the value that is considered the true value of the share. If the intrinsic value of Global is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Global Cord.
Please read more on our fundamental analysis page.

How important is Global Cord's Liquidity

Global Cord financial leverage refers to using borrowed capital as a funding source to finance Global Cord Blood ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Global Cord financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Global Cord's total debt and its cash.

How does Global utilize its cash?

To perform a cash flow analysis of Global Cord, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Global Cord is receiving and how much cash it distributes out in a given period. The Global Cord cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Purchase by Mccarthy Kent C of 78400 shares of Global Cord

Legal trades by Global Cord insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Global insider trading alert for perchase of common stock by Mccarthy Kent C, the corporate stakeholder, on 18th of December 2021. This event was filed by Global Cord Blood Corp with SEC on 2014-12-18. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

A Deeper look at Global

Although in the United States, the Securities and Exchange Commission has enforced strong rules to prevent insiders from engaging in insider trading, finding insiders among active shareholders of Global Cord is not uncomon. There are few distinct groups of Global Cord stakehholders that the SEC considers insiders. Investors usually gain information through their work as corporate directors, officers, or employees. If these individuals share the information with a friend, family, or business partner and the person who receives the information exchanges stock in the company, he or shie is also an insider. Let's take a look at how the ownership of Global is distributed among investors.

Ownership Allocation

Global Cord secures a total of 121.55 Million outstanding shares. Global Cord retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company outstanding shares. 66.49 (percent) of Global Cord outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Retail Investors
Retail Investors18.45

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Global Cord has an asset utilization ratio of 26.45 percent. This suggests that the company is making $0.26 for each dollar of assets. An increasing asset utilization means that Global Cord Blood is more efficient with each dollar of assets it utilizes for everyday operations.

Current Assets
5.9 B
Assets Non Current
1.7 B
Current Assets5.89 Billion76.37
Assets Non Current1.68 Billion21.84
Goodwill88.91 Million1.15
Tax Assets49.04 Million0.64

Is Global showing proof of lower volatility?

Treynor Ratio just dropped to -1.35, may entail upcoming price decline. Global Cord Blood exhibits very low volatility with skewness of 0.38 and kurtosis of 2.23. However, we advise investors to further study Global Cord Blood technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Global Cord's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Global Cord's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

The Current Takeaway on Global Cord Investment

Whereas other companies in the diagnostics & research industry are either recovering or due for a correction, Global Cord may not be performing as strong as the other in terms of long-term growth potentials. While some institutional investors may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Global Cord.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Global Cord Blood. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to